Loading…

Effects of beta thalassemia minor on results of six glycated hemoglobin methods

Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM. Samples sub...

Full description

Saved in:
Bibliographic Details
Published in:Clinica chimica acta 2004-12, Vol.350 (1), p.123-128
Main Authors: Polage, Christopher, Little, Randie R., Rohlfing, Curt L., Cole, Thomas G., Roberts, William L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3
cites cdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3
container_end_page 128
container_issue 1
container_start_page 123
container_title Clinica chimica acta
container_volume 350
creator Polage, Christopher
Little, Randie R.
Rohlfing, Curt L.
Cole, Thomas G.
Roberts, William L.
description Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM. Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays. The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 ( p=0.051). Further investigation demonstrated an increase in Synchron %HbA 1c results with decreasing hemoglobin concentrations. In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.
doi_str_mv 10.1016/j.cccn.2004.07.015
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67047917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898104003766</els_id><sourcerecordid>67047917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</originalsourceid><addsrcrecordid>eNp9kM9LwzAUx4Mobk7_AQ-Sk7fWlyZtWvAiMn_AYBc9hzR92TLaZiaduP_ejg28eXg8Hny-X3gfQm4ZpAxY8bBJjTF9mgGIFGQKLD8jU1ZKnnBRZedkCgBVUlYlm5CrGDfjKaBgl2TC8pyDKMopWc6tRTNE6i2tcdB0WOtWx4id07RzvQ_U9zRg3LVHKLofumr3Rg_Y0DV2ftX62vW0w2Htm3hNLqxuI96c9ox8vsw_nt-SxfL1_flpkRieZ0OSmVyiYBatBgtmHDCFkcgzbrDGmjelrhsuTZaXUou6QSyE4LKWIhPaWj4j98febfBfO4yD6lw02La6R7-LqpAgZMXkCGZH0AQfY0CrtsF1OuwVA3XQqDbqoFEdNCqQatQ4hu5O7bu6w-YvcvI2Ao9HAMcfvx0GFY3D3mDjwqhTNd791_8LD2KFDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67047917</pqid></control><display><type>article</type><title>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</title><source>ScienceDirect Journals</source><creator>Polage, Christopher ; Little, Randie R. ; Rohlfing, Curt L. ; Cole, Thomas G. ; Roberts, William L.</creator><creatorcontrib>Polage, Christopher ; Little, Randie R. ; Rohlfing, Curt L. ; Cole, Thomas G. ; Roberts, William L.</creatorcontrib><description>Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM. Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays. The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 ( p=0.051). Further investigation demonstrated an increase in Synchron %HbA 1c results with decreasing hemoglobin concentrations. In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cccn.2004.07.015</identifier><identifier>PMID: 15530468</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Anemia ; Beta thalassemia minor ; beta-Thalassemia - metabolism ; Biological Assay - methods ; Diabetes Mellitus, Type 1 - blood ; Evaluation Studies as Topic ; False elevation ; Glycated hemoglobin ; Glycated Hemoglobin A - analysis ; Glycated Hemoglobin A - metabolism ; HbA 1c ; Hematologic Tests - methods ; Humans ; Phenotype ; Regression Analysis ; Sensitivity and Specificity</subject><ispartof>Clinica chimica acta, 2004-12, Vol.350 (1), p.123-128</ispartof><rights>2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</citedby><cites>FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15530468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polage, Christopher</creatorcontrib><creatorcontrib>Little, Randie R.</creatorcontrib><creatorcontrib>Rohlfing, Curt L.</creatorcontrib><creatorcontrib>Cole, Thomas G.</creatorcontrib><creatorcontrib>Roberts, William L.</creatorcontrib><title>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM. Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays. The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 ( p=0.051). Further investigation demonstrated an increase in Synchron %HbA 1c results with decreasing hemoglobin concentrations. In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.</description><subject>Adult</subject><subject>Anemia</subject><subject>Beta thalassemia minor</subject><subject>beta-Thalassemia - metabolism</subject><subject>Biological Assay - methods</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Evaluation Studies as Topic</subject><subject>False elevation</subject><subject>Glycated hemoglobin</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>HbA 1c</subject><subject>Hematologic Tests - methods</subject><subject>Humans</subject><subject>Phenotype</subject><subject>Regression Analysis</subject><subject>Sensitivity and Specificity</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp9kM9LwzAUx4Mobk7_AQ-Sk7fWlyZtWvAiMn_AYBc9hzR92TLaZiaduP_ejg28eXg8Hny-X3gfQm4ZpAxY8bBJjTF9mgGIFGQKLD8jU1ZKnnBRZedkCgBVUlYlm5CrGDfjKaBgl2TC8pyDKMopWc6tRTNE6i2tcdB0WOtWx4id07RzvQ_U9zRg3LVHKLofumr3Rg_Y0DV2ftX62vW0w2Htm3hNLqxuI96c9ox8vsw_nt-SxfL1_flpkRieZ0OSmVyiYBatBgtmHDCFkcgzbrDGmjelrhsuTZaXUou6QSyE4LKWIhPaWj4j98febfBfO4yD6lw02La6R7-LqpAgZMXkCGZH0AQfY0CrtsF1OuwVA3XQqDbqoFEdNCqQatQ4hu5O7bu6w-YvcvI2Ao9HAMcfvx0GFY3D3mDjwqhTNd791_8LD2KFDQ</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Polage, Christopher</creator><creator>Little, Randie R.</creator><creator>Rohlfing, Curt L.</creator><creator>Cole, Thomas G.</creator><creator>Roberts, William L.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</title><author>Polage, Christopher ; Little, Randie R. ; Rohlfing, Curt L. ; Cole, Thomas G. ; Roberts, William L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Anemia</topic><topic>Beta thalassemia minor</topic><topic>beta-Thalassemia - metabolism</topic><topic>Biological Assay - methods</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Evaluation Studies as Topic</topic><topic>False elevation</topic><topic>Glycated hemoglobin</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>HbA 1c</topic><topic>Hematologic Tests - methods</topic><topic>Humans</topic><topic>Phenotype</topic><topic>Regression Analysis</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polage, Christopher</creatorcontrib><creatorcontrib>Little, Randie R.</creatorcontrib><creatorcontrib>Rohlfing, Curt L.</creatorcontrib><creatorcontrib>Cole, Thomas G.</creatorcontrib><creatorcontrib>Roberts, William L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polage, Christopher</au><au>Little, Randie R.</au><au>Rohlfing, Curt L.</au><au>Cole, Thomas G.</au><au>Roberts, William L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>350</volume><issue>1</issue><spage>123</spage><epage>128</epage><pages>123-128</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM. Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays. The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 ( p=0.051). Further investigation demonstrated an increase in Synchron %HbA 1c results with decreasing hemoglobin concentrations. In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>15530468</pmid><doi>10.1016/j.cccn.2004.07.015</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-8981
ispartof Clinica chimica acta, 2004-12, Vol.350 (1), p.123-128
issn 0009-8981
1873-3492
language eng
recordid cdi_proquest_miscellaneous_67047917
source ScienceDirect Journals
subjects Adult
Anemia
Beta thalassemia minor
beta-Thalassemia - metabolism
Biological Assay - methods
Diabetes Mellitus, Type 1 - blood
Evaluation Studies as Topic
False elevation
Glycated hemoglobin
Glycated Hemoglobin A - analysis
Glycated Hemoglobin A - metabolism
HbA 1c
Hematologic Tests - methods
Humans
Phenotype
Regression Analysis
Sensitivity and Specificity
title Effects of beta thalassemia minor on results of six glycated hemoglobin methods
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A53%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20beta%20thalassemia%20minor%20on%20results%20of%20six%20glycated%20hemoglobin%20methods&rft.jtitle=Clinica%20chimica%20acta&rft.au=Polage,%20Christopher&rft.date=2004-12-01&rft.volume=350&rft.issue=1&rft.spage=123&rft.epage=128&rft.pages=123-128&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cccn.2004.07.015&rft_dat=%3Cproquest_cross%3E67047917%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67047917&rft_id=info:pmid/15530468&rfr_iscdi=true